Loading clinical trials...
Loading clinical trials...
Observational Cohort Study of Blood Transcriptomics and Proteomics Information as Biomarkers of Traumatic Encephalopathy Syndrome
Conditions
Interventions
Blood tests, Cognitive function tests, head MRI (plain scan and DTI sequence) examination and head PET (FDG-PET, Tau-PET and Amyloid-PET) examination
Locations
1
China
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China
Start Date
May 1, 2021
Primary Completion Date
December 1, 2023
Completion Date
December 1, 2023
Last Updated
January 12, 2026
NCT03724136
NCT05490576
NCT04489082
NCT04311281
NCT01891383
NCT02103894
Lead Sponsor
Tianjin Medical University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions